Screenshot of Zoom webinar panelists
340B Report's May 18 webinar panelists included (clockwise from top left) Aaron Vandervelde, Jason Atlas, Ashley Mains Espinosa, Tom Mirga, Ted Slafsky, and Sue Veer.

The New Rules of 340B Contract Pharmacy—a Recap of 340B Report’s First-Ever Webinar

340B Report held a webinar for its subscribers last week on Second Sight Solutions’ 340B ESP platform that administers drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies. More than 800 subscribers registered to attend—a clear sign that interest in 340B ESP is intense.

The drug company restrictions that 340B ESP manages are controversial. Federal courts are deciding whether they are legal, and it could be years before the courts rule definitively. In the meantime, many 340B entities face a hard choice: Reject the requirements and forfeit 340B revenues that sustain their missions or submit the data despite deep concerns about doing so.

340B Report held a webinar for its subscribers last week on Second Sight Solutions’ 340B ESP platform that administers drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer